Stock comparison
Medline Inc. is 26.0x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.89 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 26.0x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.89 B).
Market value leader
MDLN
Medline Inc. is 26.0x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.89 B).
Revenue leader
MDLN
NVCR: $655.35M vs MDLN: $28.43B.
Profit leader
MDLN
NVCR: -$136.23M vs MDLN: $1.16T.
Margin leader
MDLN
NVCR: -20.8% vs MDLN: 4069.4% net margin.
| Metric | NVCR | MDLN |
|---|---|---|
| Market cap | $1.89 B | $49.12 B |
| US-listed rank | #2189 | #330 |
| Revenue (latest FY) | $655.35M | $28.43B |
| Net income (latest FY) | -$136.23M | $1.16T |
| Net margin | -20.8% | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 1,138 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 26.0x more valuable than NovoCure Ltd by market capitalization ($49.12 B vs $1.89 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while Medline Inc. reported $28.43B.
Full pages: NovoCure Ltd and Medline Inc., or browse the full rankings.